![]() ![]() Please refer to the ODB formulary for nutritional products and diabetic test strips that are covered on the ODB Program. Please note, the EAP does not consider funding for non-drug products which includes diabetic test strips, medical or assistive devices, natural health products, or nutritional products. The CED also makes recommendations as to whether or not drug products should be available through EAP, and may develop clinical criteria. The CED then makes recommendations to the Executive Officer as to whether a drug product should be listed as a Formulary benefit or designated as an interchangeable drug product (for generic drugs). For manufacturer-initiated reviews, each complete submission undergoes a rigorous review by the CED. Typically the CED recommends consideration through EAP for drug products where strong clinical evidence is not available to support efficacy and/or cost-effectiveness, when compared to other drugs already funded through the ODB program.ĮAP requests are only considered for a drug or indication which has been approved for funding by the Executive Officer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |